- $19.27bn
- $43.31bn
- CA$11.52bn
- 77
- 72
- 68
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,783 | 8,935 | 9,448 | 11,043 | 11,517 |
Cost of Revenue | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,734 | 6,427 | 6,979 | 8,303 | 8,410 |
Operating Profit | 3,049 | 2,508 | 2,469 | 2,740 | 3,107 |
Allowance for Funds Used During Construction | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,141 | 1,620 | 1,639 | 1,803 | 2,070 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,852 | 1,389 | 1,405 | 1,514 | 1,710 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,722 | 1,274 | 1,294 | 1,394 | 1,573 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,655 | 1,209 | 1,231 | 1,330 | 1,506 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.62 | 2.6 | 2.61 | 2.78 | 3.06 |
Dividends per Share |